Skip to main content
Erschienen in: Virchows Archiv 5/2011

01.11.2011 | Original Article

A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies

verfasst von: Mariana Catta-Preta, Leonardo Souza Mendonca, Julio Fraulob-Aquino, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda

Erschienen in: Virchows Archiv | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

The issue of adequately quantitatively evaluating hepatic steatosis is still unresolved. Therefore, we compared three methods of quantitative assessment. Two groups of mice (n = 10 each) were fed standard chow (10% fat, SC group) or a high-fat diet (60% fat, HF group) for 16 weeks, and hepatic triglyceride (HT) and liver tissue were then studied. Paraplast-embedded tissues stained by hematoxylin and eosin (H-E) were compared to frozen sections stained by Oil Red-O (ORO). In addition, the volume density of steatosis (Vv[steatosis, liver]) was measured by point counting (P-C, sections H-E or ORO) or by image analysis (I-A, sections ORO). HT was significantly higher in the HF group (104% greater, P = 0.0004) than in the SC group. With P-C and H-E, Vv[steatosis, liver] was 4.80 ± 0.90% in the SC group and 33.50 ± 3.17% in the HF group (600% greater, P < 0.0001). With P-C and ORO, Vv[steatosis, liver] was 4.86 ± 0.89% in the SC group and 25.21 ± 1.27% in the HF group (420% greater, P < 0.0001). With I-A and ORO, Vv[steatosis, liver] was 4.17 ± 0.85% in the SC group and 23.35 ± 1.58% in the HF group (460% greater, P < 0.0001). Correlations between Vv[steatosis, liver] and HT were strong and significant in all methods. In conclusion, all methods were appropriate and reproducible. In P-C and H-E, there is a slight overestimation of steatosis in the HF animals in comparison to frozen sections and ORO; in frozen sections, differences between P-C and I-A are insignificant.
Literatur
1.
2.
Zurück zum Zitat Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395PubMedCrossRef Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395PubMedCrossRef
3.
Zurück zum Zitat Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112PubMedCrossRef Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112PubMedCrossRef
4.
Zurück zum Zitat Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16:5286–5296PubMedCrossRef Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16:5286–5296PubMedCrossRef
5.
Zurück zum Zitat Burt AD, Mutton A, Day CP (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15:246–258PubMed Burt AD, Mutton A, Day CP (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15:246–258PubMed
7.
Zurück zum Zitat Tannapfel A, Denk H, Dienes H-P, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B (2011) Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Archiv 458:511–523PubMedCrossRef Tannapfel A, Denk H, Dienes H-P, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B (2011) Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Archiv 458:511–523PubMedCrossRef
8.
Zurück zum Zitat van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256:159–168PubMedCrossRef van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256:159–168PubMedCrossRef
9.
Zurück zum Zitat El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691–697PubMedCrossRef El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691–697PubMedCrossRef
10.
Zurück zum Zitat Adams LA, Angulo P (2007) Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Clin Liver Dis 11:25–35, viii. Adams LA, Angulo P (2007) Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Clin Liver Dis 11:25–35, viii.
11.
Zurück zum Zitat Contos MJ, Sanyal AJ (2002) The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 9:37–51PubMedCrossRef Contos MJ, Sanyal AJ (2002) The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 9:37–51PubMedCrossRef
12.
Zurück zum Zitat Franzen LE, Ekstedt M, Kechagias S, Bodin L (2005) Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 18:912–916PubMedCrossRef Franzen LE, Ekstedt M, Kechagias S, Bodin L (2005) Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 18:912–916PubMedCrossRef
13.
Zurück zum Zitat Liquori GE, Calamita G, Cascella D, Mastrodonato M, Portincasa P, Ferri D (2009) An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis. Histol Histopathol 24:49–60PubMed Liquori GE, Calamita G, Cascella D, Mastrodonato M, Portincasa P, Ferri D (2009) An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis. Histol Histopathol 24:49–60PubMed
14.
Zurück zum Zitat Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951PubMed Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951PubMed
15.
Zurück zum Zitat Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA (2010) A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46:212–223PubMedCrossRef Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA (2010) A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46:212–223PubMedCrossRef
16.
Zurück zum Zitat Souza-Mello V, Gregorio BM, Cardoso-de-Lemos FS, de Carvalho L, Aguila MB, Mandarim-de-Lacerda CA (2010) Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin Sci (Lond) 119:239–250CrossRef Souza-Mello V, Gregorio BM, Cardoso-de-Lemos FS, de Carvalho L, Aguila MB, Mandarim-de-Lacerda CA (2010) Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin Sci (Lond) 119:239–250CrossRef
17.
Zurück zum Zitat Vieira VJ, Valentine RJ, Wilund KR, Woods JA (2009) Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice. Cytokine 46:339–345PubMedCrossRef Vieira VJ, Valentine RJ, Wilund KR, Woods JA (2009) Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice. Cytokine 46:339–345PubMedCrossRef
18.
Zurück zum Zitat Aguila MB, Pinheiro AR, Parente LB, Mandarim-de-Lacerda CA (2003) Dietary effect of different high-fat diet on rat liver stereology. Liver Int 23:363–370PubMedCrossRef Aguila MB, Pinheiro AR, Parente LB, Mandarim-de-Lacerda CA (2003) Dietary effect of different high-fat diet on rat liver stereology. Liver Int 23:363–370PubMedCrossRef
19.
Zurück zum Zitat Mandarim-de-Lacerda CA, Fernandes-Santos C, Aguila MB (2010) Image analysis and quantitative morphology. Methods Mol Biol 611:211–225PubMedCrossRef Mandarim-de-Lacerda CA, Fernandes-Santos C, Aguila MB (2010) Image analysis and quantitative morphology. Methods Mol Biol 611:211–225PubMedCrossRef
20.
Zurück zum Zitat Marques CM, Motta VF, Torres TS, Aguila MB, Mandarim-de-Lacerda CA (2010) Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 43:467–475PubMedCrossRef Marques CM, Motta VF, Torres TS, Aguila MB, Mandarim-de-Lacerda CA (2010) Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 43:467–475PubMedCrossRef
21.
Zurück zum Zitat Nascimento FA, Barbosa-da-Silva S, Fernandes-Santos C, Mandarim-de-Lacerda CA, Aguila MB (2010) Adipose tissue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n − 3 fatty acid rich oil). Exp Toxicol Pathol 62:17–25PubMedCrossRef Nascimento FA, Barbosa-da-Silva S, Fernandes-Santos C, Mandarim-de-Lacerda CA, Aguila MB (2010) Adipose tissue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n − 3 fatty acid rich oil). Exp Toxicol Pathol 62:17–25PubMedCrossRef
22.
Zurück zum Zitat Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195–203PubMedCrossRef Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195–203PubMedCrossRef
23.
Zurück zum Zitat Ahishali E, Demir K, Ahishali B, Akyuz F, Pinarbasi B, Poturoglu S, Ibrisim D, Gulluoglu M, Ozdil S, Besisik F, Kaymakoglu S, Boztas G, Cakaloglu Y, Mungan Z, Canberk Y, Okten A (2010) Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? J Gastroenterol Hepatol 25:619–626PubMedCrossRef Ahishali E, Demir K, Ahishali B, Akyuz F, Pinarbasi B, Poturoglu S, Ibrisim D, Gulluoglu M, Ozdil S, Besisik F, Kaymakoglu S, Boztas G, Cakaloglu Y, Mungan Z, Canberk Y, Okten A (2010) Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? J Gastroenterol Hepatol 25:619–626PubMedCrossRef
24.
Zurück zum Zitat Straub BK, Schirmacher P (2010) Pathology and biopsy assessment of non-alcoholic fatty liver disease. Dig Dis 28:197–202PubMedCrossRef Straub BK, Schirmacher P (2010) Pathology and biopsy assessment of non-alcoholic fatty liver disease. Dig Dis 28:197–202PubMedCrossRef
25.
Zurück zum Zitat Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, Jimenez Romero C, Garcia Garcia I, Loinzaz Segurola C, Gonzalez P, Gomez Sanz R (1998) Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 22:837–844PubMedCrossRef Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, Jimenez Romero C, Garcia Garcia I, Loinzaz Segurola C, Gonzalez P, Gomez Sanz R (1998) Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 22:837–844PubMedCrossRef
26.
Zurück zum Zitat Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474PubMedCrossRef Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474PubMedCrossRef
27.
Zurück zum Zitat Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarc’h A, Deugnier Y (2001) Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 116:263–270PubMedCrossRef Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarc’h A, Deugnier Y (2001) Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 116:263–270PubMedCrossRef
28.
Zurück zum Zitat Sanyal AJ (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705–1725PubMedCrossRef Sanyal AJ (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705–1725PubMedCrossRef
29.
Zurück zum Zitat Turlin B, Ramm GA, Purdie DM, Laine F, Perrin M, Deugnier Y, Macdonald GA (2009) Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies. Liver Int 29:530–535PubMedCrossRef Turlin B, Ramm GA, Purdie DM, Laine F, Perrin M, Deugnier Y, Macdonald GA (2009) Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies. Liver Int 29:530–535PubMedCrossRef
30.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321PubMedCrossRef Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321PubMedCrossRef
31.
Zurück zum Zitat Wieckowska A, Feldstein AE (2008) Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28:386–395PubMedCrossRef Wieckowska A, Feldstein AE (2008) Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28:386–395PubMedCrossRef
32.
Zurück zum Zitat Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42:503–508PubMedCrossRef Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42:503–508PubMedCrossRef
33.
Zurück zum Zitat Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES (2010) Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 52:579–585PubMedCrossRef Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES (2010) Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 52:579–585PubMedCrossRef
34.
Zurück zum Zitat Cruz-Orive LM, Weibel ER (1990) Recent stereological methods for cell biology: a brief survey. Am J Physiol 258:L148–156PubMed Cruz-Orive LM, Weibel ER (1990) Recent stereological methods for cell biology: a brief survey. Am J Physiol 258:L148–156PubMed
35.
Zurück zum Zitat Weibel ER (1989) Measuring through the microscope: development and evolution of stereological methods. J Microsc 155:393–403PubMedCrossRef Weibel ER (1989) Measuring through the microscope: development and evolution of stereological methods. J Microsc 155:393–403PubMedCrossRef
36.
Zurück zum Zitat Souza-Mello V, Mandarim-de-Lacerda CA, Aguila MB (2007) Hepatic structural alteration in adult programmed offspring (severe maternal protein restriction) is aggravated by post-weaning high-fat diet. Br J Nutr 98:1159–1169PubMedCrossRef Souza-Mello V, Mandarim-de-Lacerda CA, Aguila MB (2007) Hepatic structural alteration in adult programmed offspring (severe maternal protein restriction) is aggravated by post-weaning high-fat diet. Br J Nutr 98:1159–1169PubMedCrossRef
37.
Zurück zum Zitat Rawlins SR, El-Zammar O, Zinkievich JM, Newman N, Levine RA (2010) Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naive patients with chronic hepatitis C. Dig Dis Sci 55:2049–2057PubMedCrossRef Rawlins SR, El-Zammar O, Zinkievich JM, Newman N, Levine RA (2010) Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naive patients with chronic hepatitis C. Dig Dis Sci 55:2049–2057PubMedCrossRef
38.
Zurück zum Zitat Nakano S, Nagasawa T, Ijiro T, Inada Y, Tamura T, Maruyama K, Kuroda J, Yamazaki Y, Kusama H, Shibata N (2008) Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line. Hepatol Res 38:1026–1039PubMedCrossRef Nakano S, Nagasawa T, Ijiro T, Inada Y, Tamura T, Maruyama K, Kuroda J, Yamazaki Y, Kusama H, Shibata N (2008) Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line. Hepatol Res 38:1026–1039PubMedCrossRef
39.
Zurück zum Zitat Neves RH, de Barros M, Alencar AC, Costa-Silva M, Aguila MB, Mandarim-de-Lacerda CA, Machado-Silva JR, Gomes DC (2007) Long-term feeding a high-fat diet causes histological and parasitological effects on murine schistosomiasis mansoni outcome. Exp Parasitol 115:324–332PubMedCrossRef Neves RH, de Barros M, Alencar AC, Costa-Silva M, Aguila MB, Mandarim-de-Lacerda CA, Machado-Silva JR, Gomes DC (2007) Long-term feeding a high-fat diet causes histological and parasitological effects on murine schistosomiasis mansoni outcome. Exp Parasitol 115:324–332PubMedCrossRef
40.
Zurück zum Zitat DeLeve LD, Wang X, Kanel GC, Atkinson RD, McCuskey RS (2008) Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am J Pathol 173:993–1001PubMedCrossRef DeLeve LD, Wang X, Kanel GC, Atkinson RD, McCuskey RS (2008) Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am J Pathol 173:993–1001PubMedCrossRef
41.
Zurück zum Zitat Neves RH, Alencar AC, Aguila MB, Mandarim-de-Lacerda CA, Machado-Silva JR, Gomes DC (2007) Light and confocal microscopic observations of adult Schistosoma mansoni from mice fed on a high-fat diet. J Helminthol 81:361–368PubMedCrossRef Neves RH, Alencar AC, Aguila MB, Mandarim-de-Lacerda CA, Machado-Silva JR, Gomes DC (2007) Light and confocal microscopic observations of adult Schistosoma mansoni from mice fed on a high-fat diet. J Helminthol 81:361–368PubMedCrossRef
42.
Zurück zum Zitat Tschanz SA, Burri PH, Weibel ER (2011) A simple tool for stereological assessment of digital images: the STEPanizer. J Microsc 243(Pt 1):47–59PubMedCrossRef Tschanz SA, Burri PH, Weibel ER (2011) A simple tool for stereological assessment of digital images: the STEPanizer. J Microsc 243(Pt 1):47–59PubMedCrossRef
Metadaten
Titel
A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies
verfasst von
Mariana Catta-Preta
Leonardo Souza Mendonca
Julio Fraulob-Aquino
Marcia Barbosa Aguila
Carlos Alberto Mandarim-de-Lacerda
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 5/2011
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-011-1147-1

Weitere Artikel der Ausgabe 5/2011

Virchows Archiv 5/2011 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …